References

Cancer Research UK. Tobacco statistics. 2022. https://www.cancerresearchuk.org/health-professional/cancer-statistics/risk/tobacco (accessed 25 September 2022)

Davidson J. Seizures and bupropion: a review. J Clin Psychiatry. 1989; 50:(7)256-261

Ferguson SG, Schüz B, Gitchell JG. Use of smoking cessation aids: role of perceived safety and efficacy. Journal of Smoking Cessation. 2012; 7:(1)1-3 https://doi.org/10.1017/jsc.2012.11

gov.UK. Tobacco and smoking: policy, regulation and guidance. 2021. https://www.gov.uk/government/collections/tobacco-and-smoking-policy-regulation-and-guidance (accessed 6 September 2022)

Hartmann-Boyce J, McRobbie H, Butler AR Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2021; 9:(CD010216) https://doi.org/10.1002/14651858.CD010216.pub6

Hughes JR, Stead LF, Hartmann-Boyce J Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2014; 2014:(1) https://doi.org/10.1002/14651858.CD000031.pub4

Hukkanen J, Jacob P, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev. 2005; 57:(1)79-115 https://doi.org/10.1124/pr.57.1.3

Jackson SE, Cox S, Shahab L, Brown J. Prevalence of use and real-world effectiveness of smoking cessation aids during the COVID-19 pandemic: a representative study of smokers in England. Addiction. 2022; 117:(9)2504-2514 https://doi.org/10.1111/add.15903

Lindson N, Thompson TP, Ferrey A, Lambert JD, Aveyard P. Motivational interviewing for smoking cessation (Review). Cochrane Database of Systematic Reviews. 2019a; 7 https://doi.org/10.1002/14651858.CD006936.pub4

Lindson N, Chepkin SC, Ye W Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2019b; 4:(4) https://doi.org/10.1002/14651858.CD013308

Very brief advice on smoking. 2012. www.nursingtimes.net/clinical-archive/smoking-cessation/very-brief-advice-on-smoking-24-02-2012/ (accessed 9 September 2022)

Mendelsohn C. Optimal use of smoking cessation pharmacotherapy. Aust Prescr. 2022; 45:(1)10-14 https://doi.org/10.18773/austprescr.2022.001

National Centre for Smoking Cessation and Training Very brief advice training module. 2022. https://www.ncsct.co.uk/publication_very-brief-advice.php (accessed 9 September 2022)

NHS Medicines. Champix-Varenicline. 2022. https://www.nhs.uk/medicines/champix-varenicline/ (accessed 8 September 2022)

National Institute for Health and Care Excellence. Tobacco: preventing uptake, promoting quitting and treating dependence. Guideline 209. 2021. www.nice.org.uk/guidance/ng209 (accessed 6 September 2022)

Notley C, Ward E, Dawkins L, Holland R. The unique contribution of e-cigarettes for tobacco harm reduction in supporting smoking relapse prevention. Harm Reduct J. 2018; 15:(1) https://doi.org/10.1186/s12954-018-0237-7

Papadakis S, Anastasaki M, Papadakaki M ‘Very brief advice’ (VBA) on smoking in family practice: a qualitative evaluation of the tobacco user's perspective. BMC Fam Pract. 2020; 21:(1) https://doi.org/10.1186/s12875-020-01195-w

Pipe AL, Evans W, Papadakis S. Smoking cessation: health system challenges and opportunities. Tob Control. 2022; 31:(2)340-347 https://doi.org/10.1136/tobaccocontrol-2021-056575

Pourchez J, Mercier C, Forest V. From smoking to vaping: a new environmental threat?. Lancet Respir Med. 2022; 10:(7)e63-e64 https://doi.org/10.1016/S2213-2600(22)00187-4

Never give up encouraging patients to give up smoking - implementing guidelines. 2022. https://www.guidelinesinpractice.co.uk/smoking-cessation/never-give-up-encouraging-patients-to-give-up-smoking/456885.article (accessed 5 September 2022)

Royal College of Physicians. Smoking and Health 1962. 1962. https://www.rcplondon.ac.uk/projects/outputs/smoking-and-health-1962 (accessed 25 September 2022)

Royal College of Physicians. Nicotine without smoke: tobacco harm reduction. 2016. https://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction (accessed 26 September 2022)

Royal College of Physicians. Smoking and health 2021: a coming of age for tobacco control?. 2021. https://www.rcplondon.ac.uk/projects/outputs/smoking-and-health-2021-coming-age-tobacco-control (accessed 25 September 2022)

Shiffman S, Sembower MA, Rohay JM, Gitchell JG, Garvey AJ. Assigning dose of nicotine gum by time to first cigarette. Nic Tob Res. 2013; 15:407-12 https://doi.org/10.1093/ntr/nts141

Sivaramakrishnan G, Alsobaiei M, Sridharan K. Oral side effects of locally delivered nicotine replacement therapy: A meta-analysis of randomized controlled trials. Int J Dent Hyg. 2023; 21:(1)3-17 https://doi.org/10.1111/idh.12594

Stead LF, Lancaster T. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev. 2012; 12 https://doi.org/10.1002/14651858.cd010216.pub5

Managing smoking cessation in primary care

02 April 2023
Volume 5 · Issue 4

Abstract

Smoking remains a significant preventable cause of serious chronic diseases. Smokers should be advised about quitting at every opportunity, using very brief advice as a quick and reliable method to instigate empathetic support and understanding, which encourages smokers to consider quitting. Nicotine replacement therapy, especially combining a long-release and short-release formulae, should be the first step in the use of pharmaceutical aids. Ideally, heavily dependent smokers should also be prescribed varenicline, but this is currently unavailable in the UK. An alternative is bupropion, which should be a consideration. However, it is less effective, with more side effects. Electronic cigarettes have been recommended as a suitable quitting aid, and also for harm reduction in those who are not yet ready to stop smoking.

The UK has experienced a dramatic reduction in smoking prevalence of about 75% over the last 60 years (Royal College of Physicians (RCP), 2021). However, if the recent, rather slow, rate of reduction continues, it is predicted that the UK will still be a long way from eradicating smoking by 2050, a plan that was advocated in the 1962 UK White Paper ‘Smoking and Health’ (RCP, 1962). Despite the reduction in smoking prevalence in the UK, smoking remains the most important avoidable cause of premature death and disability in the UK, and the biggest preventable cause of cancer. The latest figures show that 14.1% of people aged 18 years or older smoke cigarettes, which equates to around 6.9 million individuals (Cancer Research UK, 2022). Worryingly, a new study found that the number of 18–34-year-olds in England who smoke, increased by 25% during the first lockdown, meaning that there are over 652 000 more young adults who smoke than before the pandemic (Jackson et al, 2022).

Register now to continue reading

Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month